Related Experiment Videos

[Toxicity of sequential chemo-radiotherapy in radically operated ovarian cancer]

E Petru¹, H Pickel, M Lahousen

¹Geburtshilflich-gynäkologische Universitätsklinik Graz.

Gynakologische Rundschau

|January 1, 1990

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Quality of life in patients with advanced epithelial ovarian cancer (EOC) randomized to maintenance pazopanib or placebo after first-line chemotherapy in the AGO-OVAR 16 trial. Measuring what matters-patient-centered end points in trials of maintenance therapy.

Annals of oncology : official journal of the European Society for Medical Oncology·2017

Topotecan plus carboplatin versus standard therapy with paclitaxel plus carboplatin (PC) or gemcitabine plus carboplatin (GC) or pegylated liposomal doxorubicin plus carboplatin (PLDC): a randomized phase III trial of the NOGGO-AGO-Study Group-AGO Austria and GEICO-ENGOT-GCIG intergroup study (HECTOR).

Annals of oncology : official journal of the European Society for Medical Oncology·2016

[Peripartum aortic dissection].

Der Anaesthesist·2013

Carboplatin-paclitaxel-induced leukopenia and neuropathy predict progression-free survival in recurrent ovarian cancer.

British journal of cancer·2011

Influence of inflammatory reaction in primary fallopian-tube carcinoma (stage-I and stage-ii).

Oncology reports·2011

Ovarian cancer in elderly patients: carboplatin and pegylated liposomal doxorubicin versus carboplatin and paclitaxel in late relapse: a Gynecologic Cancer Intergroup (GCIG) CALYPSO sub-study.

Annals of oncology : official journal of the European Society for Medical Oncology·2011

See all related articles